Drug Therapy and Diabetes Management

Drug Therapy for Fluid Volume Excess

Kidney Function
  • Regulation of Body Fluids: The kidneys play a vital role in regulating volume, composition, and pH of body fluids.
  • Requirements for Kidney Function: Adequate blood flow is crucial for kidney function.
  • Components of the Nephron: Key structural units include the glomerulus and tubules (specifically the loop of Henle).
  • Key Processes:
    • Glomerular Filtration: The process where blood is filtered in the glomerulus.
    • Tubular Reabsorption: Substances are reabsorbed from the tubules back into the blood, maintaining necessary body fluid levels.
    • Tubular Secretion: Substances are secreted from the blood into the urine, facilitating waste removal.
Fluid Volume Excess
  • Impact: Fluid volume excess can alter cardiovascular, renal, and hepatic functions.
  • Edema: Fluid may leave the bloodstream into interstitial spaces, a phenomenon known as "third spacing." This can manifest as:
    • Dependent Edema: Swelling in lower parts of the body due to gravity (e.g., ankles).
    • Pulmonary Edema: Fluid accumulating in the lungs, leading to respiratory distress.
    • Anasarca: Severe, widespread edema.
Drug Therapy: Diuretics
  • Function of Diuretics: Decrease reabsorption of sodium, chloride, and water to increase urine output, addressing conditions like edema, heart failure, and hypertension.
  • Monitoring: Important to monitor fluid intake and output (I+O) to prevent dehydration.
Types of Diuretics

  1. Loop Diuretics:

    • Examples: Furosemide, Bumetanide, and Torsemide.
    • Usage: Especially effective in acute situations like renal failure.
    • Diet: A low sodium diet is often recommended.
    • Adverse Effects: Include hyponatremia, hypokalemia, ototoxicity (slow IV push advised), and dehydration.
    • Contraindications: Include anuria and sulfonamide allergy.

  2. Thiazide Diuretics:

    • Examples: Hydrochlorothiazide (HCTZ) and Metolazone.
    • Requirement: Adequate urine flow is needed for effectiveness, often used in heart failure, hypertension, and nephrotic syndrome.
    • Adverse Effects: Hypotension, hyponatremia, hypokalemia, erectile dysfunction, and dehydration.
    • Contraindications: Anuria, sulfonamide allergy, pregnancy.

  3. Potassium-Sparing Diuretics:

    • Examples: Spironolactone, Amiloride, and Triamterene.
    • Mechanism: Help preserve potassium while removing sodium.
    • Indications: Used in heart failure and hyperaldosteronism.
    • Adverse Effects: Includes voice changes, gynecomastia, menstrual irregularities, hyperkalemia.
    • BBW (Black Box Warning): Potential for tumorigenicity.
    • Contraindications: Include anuria and pregnancy.

  4. Osmotic Diuretics:

    • Example: Mannitol.
    • Function: Pulls water from extravascular spaces into the bloodstream, useful when renal circulation and GFR are low.
    • Applications: Reduce intracranial and intraocular pressure, particularly in glaucoma.

Drug Therapy for Diabetes Mellitus

Definition and Classification
  • Diabetes Mellitus: A metabolic disorder characterized by chronic hyperglycemia.
  • Hyperglycemia Definition: Fasting blood sugar of at least 126 mg/dL, while prediabetes indicates levels between 100-125 mg/dL.
  • HbA1c: High blood sugar levels can adversely affect various systems including the vascular system, eyes, and kidneys.
Types of Diabetes

  1. Type 1 Diabetes Mellitus (T1DM):

    • Nature: An autoimmune disorder leading to the destruction of pancreatic beta cells.
    • Onset: Often diagnosed in childhood, though it can occur in adults.
    • Treatment: Requires insulin for management.
    • Complications: Risk of diabetic ketoacidosis (DKA) and renal failure.

  2. Type 2 Diabetes Mellitus (T2DM):

    • Mechanism: Characterized by insulin resistance.
    • Onset: Gradual, associated with obesity and sedentary lifestyles, and does not always require insulin.
    • Complications: Myocardial infarction and strokes.
Physiology of Insulin
  • Origin: Secreted by pancreatic beta cells along with amylin.
  • Action of Insulin: Targets cell receptors, promoting glucose uptake, decreasing blood glucose levels, and stimulating antibiotic effects.
  • Incretin Hormones: Increase insulin release triggered by food in the GI tract, inhibition of insulin secretion can occur due to hypoxia, hypothermia, surgery, or burns.
  • Other Hormones: Glucagon raises blood glucose levels. Cortisol, growth hormone, epinephrine, estrogen, and progesterone also increase glucose levels.
Medications Impacting Blood Sugar
Drugs That Raise Blood Sugar:
  • Examples: Corticosteroids, thiazide diuretics, estrogens/contraceptives, glucagon, phenytoin, levothyroxine.
Drugs That Lower Blood Sugar:
  • Examples: Anti-diabetics and antibiotics.
Clinical Manifestations of Hyperglycemia
  • Symptoms: Polyuria (excessive urination), polydipsia (excessive thirst), polyphagia (excessive hunger), dehydration, DKA, and hyperosmolar hyperglycemic nonketotic coma.
  • DKA Symptoms: Include nausea/vomiting, dehydration, tachycardia, hypotension, kussmaul respirations, altered level of consciousness (LOC), leading to coma and possibly death. Management often involves hydration and regular insulin IV.
Hyperosmolar Hyperglycemic Nonketotic Coma (HANC)
  • Details: More common in T2DM; develops gradually without ketones and is typically not acidotic.
  • Symptoms: Mental status changes and risk of coma and death if untreated.
  • Treatment: Involves fluids and insulin administration.
Clinical Manifestations of Hypoglycemia
  • Common Symptoms: Hunger, sweating, pallor, irritability, tachycardia, confusion, lethargy, seizures, and death.
  • Treatment: Immediate blood sugar check, administer oral glucose if alert, otherwise provide IV dextrose or glucagon.
Drug Therapy: Insulin Details
  • Administration Forms: Regular insulin acts within 15-30 minutes, with various durations based on formulations (rapid, short, intermediate, long-acting).
  • Goal: To relieve hyperglycemia while preventing hypoglycemia.
  • Onset and Duration:
    • Rapid-Acting: Onset in 15 minutes, lasts 4-8 hours - includes insulin lispro, aspart, glulisine.
    • Intermediate: NPH insulin, mixed formulations available.
    • Long-Acting: Insulin glargine and detemir are often used for basal insulin needs.
Considerations for Insulin Management
  • Weight Changes: May impact insulin requirements.
  • Monitoring: Regular checks of A1C levels, activity level of children, and awareness of hypoglycemia.
  • Education Needs: Needed for older adults who may struggle with administration due to comorbidities.
  • Insulin Selection:
    • Regular insulin for acute situations requiring IV.
    • Combination therapies for consistent blood sugar control.
    • Long-acting insulins for basal coverage alongside short or rapid-acting insulins at mealtimes.
Other Antidiabetic Medications

  1. Sulfonylureas: (e.g., Glyburide)

    • Action: Stimulate insulin secretion in patients with functional beta cells.
    • Considerations: Watch for hypoglycemia and sulfa allergies; not recommended for children.

  2. Biguanides: (e.g., Metformin)

    • Function: Reduces glucose production by the liver and decreases intestinal absorption; does not cause hypoglycemia by itself.
    • Considerations: Can be used with insulin; avoid in renal failure due to the risk of lactic acidosis.

  3. Alpha-glucosidase Inhibitors: (e.g., Acarbose)

    • Mechanism: Delays digestion and absorption of carbohydrates, does not enhance insulin, and is best during combination therapy.
    • Adverse Effects: Gastrointestinal upset, can reduce digoxin levels.

  4. Thiazolidinediones: (e.g., Rosiglitazone)

    • Action: Decrease insulin resistance; it can take time to see effects.
    • Considerations: Risk of heart failure and other side effects such as liver injury.

  5. Meglitinides: (e.g., Repaglinide)

    • Action: Stimulates beta cells to release insulin but must be eaten with food.

  6. Dipeptidyl Peptidase-4 Inhibitors (DPP-4): (e.g., Sitagliptin)

    • Action: Prevent inactivation of incretin hormones, helpful in increasing insulin release.
    • Considerations: Watch for signs of heart failure, especially in susceptible patients.

  7. Amylin Analog: (e.g., Pramlintide)

    • Use: Useful for T1DM and T2DM, slows gastric emptying, increases satiety, and promotes weight loss; contraindicated in gastroparesis.

  8. Glucagon-like Peptide-1 Receptor Agonists: (e.g., Exenatide)

    • Use: Stimulates appropriate insulin secretion, slows gastric emptying, and halts gluconeogenesis from the liver; associated with weight loss.
    • Risks: Potential thyroid cancer and pancreatitis.

  9. SGLT2 Inhibitors: (e.g., Canagliflozin)

    • Action: Prevents glucose reabsorption in the kidneys, increasing glucose excretion.
    • Considerations: Monitor for renal impairment and balance risk of dehydration, urinary tract infections, and other adverse effects.

Drug Therapy for Nasal Congestion + Cough

Common Colds + Rhinosinusitis
  • Colds: Viral infections impacting the respiratory tract, often presenting as rhinitis.
  • Sinusitis: Inflammation in the sinus linings, typically are caused by infection.
  • Symptoms Triad: Includes purulent nasal drainage, nasal obstruction, and facial pressure/prain.
Clinical Manifestations
  • Manifestations: Nasal congestion, cough, bronchial secretions.
Non-Pharmacologic Treatments
  • Recommendations: Enhanced hydration, air humidification, throat lozenges, and honey are suggested remedies for symptom relief.

Drug Therapy for Allergic Responses

Pathophysiology
  • Histamine: A chemical mediator released during allergic responses, influencing H1, H2, and H3 receptors.
  • Receptor Functions and Clinical Implication: Stimulation of H1 receptors leads to typical allergic symptoms like bronchial constriction, increased vascular permeability, and mucosal swelling.
Types of Allergic Responses
  • Immediate (Type 1): Triggered by IgE reactions, can lead to anaphylaxis; treated with antihistamines and epinephrine.
  • Delayed Responses (Type 4): Involves T-cell reactions, relevant in scenarios like tuberculin tests.
Drug Therapy
  1. Antihistamines: Block histamine receptors, with first-generation (e.g., Diphenhydramine) causing sedation and anticholinergic effects, and second-generation (e.g., Cetirizine) offering less sedation.
  2. H2 Receptor Antagonists: Used for peptic ulcer disease; reduce stomach acid secretion.

Drug Therapy for Asthma, Airway Inflammation + Bronchoconstriction

Pathophysiological Mechanism
  • Asthma: Represents excessive airway responsiveness leading to inflammation, edema, bronchial constriction, and increased mucus production.
  • Chronic Obstructive Pulmonary Disease (COPD): Encompasses chronic bronchitis (long-term cough, mucus) and emphysema (alveoli damage).
Drug Therapies

  1. Anti-Inflammatory Agents: Steroids (e.g., Beclomethasone) suppress inflammation, acting as prophylactics.

  2. Bronchodilators:

    • Short-acting Beta Agonists (e.g., Albuterol): For immediate relief of acute bronchospasm, act within minutes.
    • Long-acting Beta Agonists (e.g., Salmeterol): For longer-term control of chronic symptoms, but are contraindicated for acute relief.

  3. Leukotriene Modifiers: (e.g., Montelukast) block leukotrienes, reducing bronchoconstriction and inflammation.

  4. Monoclonal Antibodies: (e.g., Omalizumab) assist in managing severe asthma and severe food allergies by targeting IgE.

Nutritional Support: Vitamins and Minerals

Vitamins
  1. Fat-Soluble Vitamins: A, D, E, K; stored in liver and fatty tissues, essential for various metabolic functions.
  2. Water-Soluble Vitamins: B-complex and vitamin C; crucial for growth and development, not stored in the body.
Minerals and Electrolytes
  • Vital for maintaining acid-base balance and osmotic pressure, necessary for muscle and nerve function.
  • Adverse effects can arise from deficiencies or excessive supplementation of minerals.

Weight Management Therapies

Obesity Statistics
  • Overweight and obesity have reached epidemic levels among adults and children, with significant health risks associated with excessive body fat.
Pharmacological Interventions
  1. Noradrenergic Sympathomimetic Anorexiants (e.g., Phentermine): Stimulate norepinephrine release, suppress appetite for short-term weight loss.
  2. Lipase Inhibitors (e.g., Orlistat): Block fat absorption in the digestive tract, used clinically for obesity management.

Drug Therapy for Peptic Ulcer Disease + Hyperacidity

Overview of Conditions
  • Peptic Ulcer Disease: Characterized by damage to the gastric mucosa due to factors like H. pylori infection, NSAIDs, and stress.
  • Gastroesophageal Reflux Disease (GERD): Causes reflux of gastric contents due to incompetent lower esophageal sphincter, leading to pyrosis and esophageal erosion.
Drug Classes
  1. Antacids: Neutralize gastric acid (e.g., Mylanta, Calcium Carbonate), but not for long-term use.
  2. H2 Receptor Antagonists: Reduce gastric acid output (e.g., Cimetidine).
  3. Proton Pump Inhibitors (PPIs): Highly effective for PUD and GERD (e.g., Omeprazole).
  4. Adjuvant Therapy: (e.g., Misoprostol for protection against NSAID-induced ulcers).

Note: This document is an exhaustive study guide derived from the transcript provided. Each concept has been elaborated in detail to facilitate thorough understanding.